Cabenuva Prices, Coupons and Patient Assistance Programs
Cabenuva (cabotegravir/rilpivirine) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
Cabenuva Prices
The cost for Cabenuva intramuscular suspension, extended release (200 mg-300 mg/mL) is around $4,144 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Cabenuva price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intramuscular Suspension, Extended Release
| Quantity | Per unit | Price |
|---|---|---|
| 4 milliliters | $1,035.94 | $4,143.74 |
| 6 milliliters | $1,035.14 | $6,210.86 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Cabenuva Coupons and Rebates
Cabenuva offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
There are currently no Manufacturer Promotions that we know about for this drug.
Patient Assistance Programs for Cabenuva
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Cabenuva (cabotegravir and rilpivirine) Extended Release Injections for Suspension
More information please phone: 866-316-7263 Visit Website
Provider: ViiV Healthcare Patient Assistance Program (Cabenuva)
Elligibility requirements:- *Contact program for details.
- At or below 500% of FPL
- Medically appropriate condition/diagnosis
- Must live in US, DC or Puerto Rico
- *Contact ViiV Connect for additional information at 844-588-3288 or www.viivconnect.com Medicare Part B, Part D and Medicare Advantage plan patients who need medicine that same day should ask their Patient Representative (ie, anyone involved in the delivery of the patient's healthcare and is not a family member or friend) to enroll them in ViiV Healthcare PAP by phone. Patients enrolled in a Medicare Part B, Part D and Medicare Advantage prescription drug plan must apply via mail or fax and be found eligible before medicine can be shipped.
- Cabenuva (cabotegravir and rilpivirine) Extended Release Injections for Suspension
More information please phone: 844-588-3288 Visit Website
More about Cabenuva (cabotegravir / rilpivirine)
- During Pregnancy
- Dosage Information
- Drug Interactions
- Drug class: antiviral combinations
- FDA Approval History
